vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and P10, Inc. (PX). Click either name above to swap in a different company.

P10, Inc. is the larger business by last-quarter revenue ($81.0M vs $40.7M, roughly 2.0× PETMED EXPRESS INC). P10, Inc. runs the higher net margin — 11.7% vs -26.0%, a 37.6% gap on every dollar of revenue. On growth, P10, Inc. posted the faster year-over-year revenue change (-4.7% vs -23.3%). P10, Inc. produced more free cash flow last quarter ($18.1M vs $-9.2M). Over the past eight quarters, P10, Inc.'s revenue compounded faster (10.7% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.

PETS vs PX — Head-to-Head

Bigger by revenue
PX
PX
2.0× larger
PX
$81.0M
$40.7M
PETS
Growing faster (revenue YoY)
PX
PX
+18.6% gap
PX
-4.7%
-23.3%
PETS
Higher net margin
PX
PX
37.6% more per $
PX
11.7%
-26.0%
PETS
More free cash flow
PX
PX
$27.3M more FCF
PX
$18.1M
$-9.2M
PETS
Faster 2-yr revenue CAGR
PX
PX
Annualised
PX
10.7%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
PX
PX
Revenue
$40.7M
$81.0M
Net Profit
$-10.6M
$9.5M
Gross Margin
23.3%
Operating Margin
-25.7%
31.9%
Net Margin
-26.0%
11.7%
Revenue YoY
-23.3%
-4.7%
Net Profit YoY
-1392.6%
79.0%
EPS (diluted)
$-0.50
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
PX
PX
Q4 25
$40.7M
$81.0M
Q3 25
$44.4M
$75.9M
Q2 25
$51.2M
$72.7M
Q1 25
$50.8M
$67.7M
Q4 24
$52.0M
$85.0M
Q3 24
$58.0M
$74.2M
Q2 24
$66.2M
$71.1M
Q1 24
$65.1M
$66.1M
Net Profit
PETS
PETS
PX
PX
Q4 25
$-10.6M
$9.5M
Q3 25
$-8.5M
$2.1M
Q2 25
$-34.2M
$3.4M
Q1 25
$-11.6M
$4.5M
Q4 24
$-707.0K
$5.3M
Q3 24
$2.3M
$1.4M
Q2 24
$3.8M
$7.0M
Q1 24
$-5.0M
$5.0M
Gross Margin
PETS
PETS
PX
PX
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
PX
PX
Q4 25
-25.7%
31.9%
Q3 25
-18.9%
14.1%
Q2 25
-66.7%
24.4%
Q1 25
-11.9%
16.6%
Q4 24
-0.9%
26.9%
Q3 24
1.0%
11.9%
Q2 24
6.6%
23.7%
Q1 24
-5.9%
18.3%
Net Margin
PETS
PETS
PX
PX
Q4 25
-26.0%
11.7%
Q3 25
-19.2%
2.8%
Q2 25
-66.7%
4.7%
Q1 25
-22.9%
6.7%
Q4 24
-1.4%
6.2%
Q3 24
4.0%
1.9%
Q2 24
5.7%
9.8%
Q1 24
-7.7%
7.6%
EPS (diluted)
PETS
PETS
PX
PX
Q4 25
$-0.50
$0.08
Q3 25
$-0.41
$0.02
Q2 25
$-1.65
$0.03
Q1 25
$-0.56
$0.04
Q4 24
$-0.03
$0.05
Q3 24
$0.11
$0.01
Q2 24
$0.18
$0.06
Q1 24
$-0.24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
PX
PX
Cash + ST InvestmentsLiquidity on hand
$26.9M
$28.2M
Total DebtLower is stronger
$373.2M
Stockholders' EquityBook value
$32.8M
$403.5M
Total Assets
$88.0M
$928.3M
Debt / EquityLower = less leverage
0.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
PX
PX
Q4 25
$26.9M
$28.2M
Q3 25
$36.1M
$40.0M
Q2 25
$41.1M
$33.4M
Q1 25
$54.7M
$74.4M
Q4 24
$50.1M
$67.5M
Q3 24
$52.0M
$61.5M
Q2 24
$46.0M
$31.2M
Q1 24
$55.3M
$29.0M
Total Debt
PETS
PETS
PX
PX
Q4 25
$373.2M
Q3 25
$393.4M
Q2 25
$373.0M
Q1 25
$357.2M
Q4 24
$319.8M
Q3 24
$319.4M
Q2 24
$300.6M
Q1 24
$314.0M
Stockholders' Equity
PETS
PETS
PX
PX
Q4 25
$32.8M
$403.5M
Q3 25
$43.1M
$396.8M
Q2 25
$51.5M
$388.9M
Q1 25
$85.1M
$374.3M
Q4 24
$96.2M
$386.9M
Q3 24
$96.4M
$394.1M
Q2 24
$93.5M
$396.9M
Q1 24
$96.7M
$400.1M
Total Assets
PETS
PETS
PX
PX
Q4 25
$88.0M
$928.3M
Q3 25
$100.3M
$936.0M
Q2 25
$109.8M
$932.2M
Q1 25
$148.7M
$877.4M
Q4 24
$144.8M
$869.3M
Q3 24
$146.0M
$857.0M
Q2 24
$152.7M
$823.2M
Q1 24
$169.9M
$832.8M
Debt / Equity
PETS
PETS
PX
PX
Q4 25
0.93×
Q3 25
0.99×
Q2 25
0.96×
Q1 25
0.95×
Q4 24
0.83×
Q3 24
0.81×
Q2 24
0.76×
Q1 24
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
PX
PX
Operating Cash FlowLast quarter
$-9.2M
$23.0M
Free Cash FlowOCF − Capex
$-9.2M
$18.1M
FCF MarginFCF / Revenue
-22.7%
22.3%
Capex IntensityCapex / Revenue
0.1%
6.0%
Cash ConversionOCF / Net Profit
2.43×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
PX
PX
Q4 25
$-9.2M
$23.0M
Q3 25
$-2.2M
$-8.6M
Q2 25
$-12.3M
$13.4M
Q1 25
$7.0M
$-4.7M
Q4 24
$-1.2M
$101.0M
Q3 24
$7.4M
$27.5M
Q2 24
$-8.5M
$34.8M
Q1 24
$7.1M
$11.0M
Free Cash Flow
PETS
PETS
PX
PX
Q4 25
$-9.2M
$18.1M
Q3 25
$-4.8M
$-9.5M
Q2 25
$-13.6M
$11.6M
Q1 25
$4.6M
$-6.0M
Q4 24
$-1.9M
$96.6M
Q3 24
$6.1M
$25.2M
Q2 24
$-9.2M
$33.9M
Q1 24
$5.9M
$10.7M
FCF Margin
PETS
PETS
PX
PX
Q4 25
-22.7%
22.3%
Q3 25
-10.8%
-12.6%
Q2 25
-26.5%
15.9%
Q1 25
9.1%
-8.9%
Q4 24
-3.7%
113.6%
Q3 24
10.6%
34.0%
Q2 24
-13.9%
47.7%
Q1 24
9.0%
16.2%
Capex Intensity
PETS
PETS
PX
PX
Q4 25
0.1%
6.0%
Q3 25
5.9%
1.2%
Q2 25
2.5%
2.5%
Q1 25
4.7%
1.9%
Q4 24
1.5%
5.2%
Q3 24
2.2%
3.0%
Q2 24
1.0%
1.3%
Q1 24
1.9%
0.4%
Cash Conversion
PETS
PETS
PX
PX
Q4 25
2.43×
Q3 25
-4.01×
Q2 25
3.96×
Q1 25
-1.05×
Q4 24
19.12×
Q3 24
3.18×
19.54×
Q2 24
-2.27×
4.98×
Q1 24
2.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

PX
PX

Management Fees$78.1M96%
Advisory Fees$1.8M2%

Related Comparisons